<DOC>
	<DOCNO>NCT02910895</DOCNO>
	<brief_summary>Outside set well-designed prospective clinical study , current standard preoperative RT conventionally 1,8-2 Gy fractionate regimen total dose 50 Gy 5-6 week . However , give vast diversity sarcoma subtypes , also unlikely assume uniform radiotherapeutic management optimal sarcoma alike . Other 2 Gy fraction size and/or 50 Gy total dose series investigate past exploited future , practical implementation human hamper rarity disease . This platform may form basis preclinical radiotherapy investigation .</brief_summary>
	<brief_title>Sarcoma Patient Derived Xenografts</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>Histologically confirm newly diagnose ( non ) metastatic intermediate high grade STS patient advise undergo combination radiotherapy surgery ( e.g . deep seat , and/or &gt; 5cm accord RECIST 1.1 criterion and/or grade II/III accord FNCLCC definition ) Local recurrence allow provide prior management surgery alone Age â‰¥ 18 year Able willing undergo tumor biopsy Localization sarcoma enable safe biopsy . Written inform consent Ewing sarcoma PNET family tumour , rhabdomyosarcoma ( paediatric adult ) , osteosarcomas Known coagulation disorder and/or anticoagulant medication far might interfere safe biopsy procedure ( discretion treat physician attend radiologist ) . Any psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule ; condition discuss patient registration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>